We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

106 hedge funds and large institutions have $173M invested in ARK Genomic Revolution ETF in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

89% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 18

22% more capital invested

Capital invested by funds: $142M → $173M (+$31.1M)

14% more funds holding

Funds holding: 93 → 106 (+13)

4.8% more ownership

Funds ownership: 28.71% → 33.51% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
106
Holders Change
+13
Holders Change %
+13.98%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
34
Increased
39
Reduced
15
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$11.5M
2
UBS Group
UBS Group
Switzerland
+$10M
3
CPA
Capital Planning Advisors
California
+$4.82M
4
Bank of America
Bank of America
North Carolina
+$3.62M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.73M

Top Sellers

Rank Fund Capital Flow
1
UAM
UAS Asset Management
New York
-$2.35M
2
PCM
Penserra Capital Management
California
-$1.49M
3
CAN
Claraphi Advisory Network
United States
-$1.37M
4
TRCT
Tower Research Capital (TRC)
New York
-$746K
5
HT
HAP Trading
New York
-$682K
Name Holding Trade Value Shares
Change 		Change in
Stake
JFA
101
JNBA Financial Advisors
Minnesota
$1K – – –
SBL
102
Sargent Bickham Lagudis
Colorado
$1K +$601 +18 New
CP
103
Corbenic Partners
Pennsylvania
$1K +$902 +27 New
BWP
104
Baldwin Wealth Partners
Massachusetts
$1K +$1K +30 New
UAM
105
UAS Asset Management
New York
– -$2.35M -70,000 Closed
HT
106
HAP Trading
New York
– -$682K -20,335 Closed
JWCA
107
J.W. Cole Advisors
Florida
– -$431K -12,869 Closed
LWMM
108
Legacy Wealth Management (Mississippi)
Mississippi
– -$268K -8,000 Closed
NFG
109
Next Financial Group
Texas
– -$265K -7,906 Closed
SI
110
Stephens Inc
Arkansas
– -$247K -7,372 Closed
FA
111
Fagan Associates
New York
– -$227K -6,766 Closed
PWP
112
Principle Wealth Partners
Connecticut
– -$214K -6,395 Closed
EWP
113
Engrave Wealth Partners
Texas
– -$72K -2,174 Closed
Qube Research & Technologies (QRT)
114
Qube Research & Technologies (QRT)
United Kingdom
– -$47K -1,400 Closed
Deutsche Bank
115
Deutsche Bank
Germany
– -$28K -861 Closed
BW
116
Bison Wealth
Georgia
– -$23K -700 Closed
ACM
117
Anfield Capital Management
California
– -$20K -600 Closed
First Manhattan
118
First Manhattan
New York
– -$20K -600 Closed
LAS
119
Lloyd Advisory Services
Georgia
– -$9K -280 Closed
HWM
120
Howard Wealth Management
Connecticut
– -$5K -175 Closed
HI
121
Human Investing
Oregon
– -$1K -17 Closed
SHWM
122
Silicon Hills Wealth Management
Texas
– -$137 -2 Closed
EI
123
Ellevest Inc
New York
– +$33 +1 New
Fidelity Investments
124
Fidelity Investments
Massachusetts
– +$33 +1 New
1 2 3 4
5

ARKG Hedge Fund Activity: Q1 2020 in Review

106 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2020, worth a combined $173M — up 22% from $142M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARKG positions and 18 closed out — a net gain of 16 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $11.5M. The largest seller was UAS Asset Management, exiting entirely with an estimated $2.35M sold.

  • 106 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2020, up from 93 in Q4 2019.
  • Funds reported $173M of ARK Genomic Revolution ETF stock for Q1 2020, up 22% quarter-over-quarter.
  • 34 funds opened new ARK Genomic Revolution ETF positions in Q1 2020 and 18 closed out, a net change of +16 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2020 was Morgan Stanley, an estimated $11.5M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2020 was UAS Asset Management, an estimated $2.35M sold.

Based on aggregated 13F filings for Q1 2020.